EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review

Yingzhe Luo, Xuebin Cai, Biao Yang, Facheng Lu, Cheng Yi, Guoyu Wu

Frontiers in Oncology · 26.08.2024 · 14

DOI: 10.3389/fonc.2024.1402837 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 26.08.2024. Verfasst von Yingzhe Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphocyte activation gene 3 (LAG-3), also known as CD223, is an emerging immune checkpoint that follows PD-1 and CTLA-4. Several LAG-3 targeting inhibitors in clinical trials and the combination of relatlimab (anti-LAG-3) and nivolumab (anti-PD-1) have been approved for treating - unresectable or metastatic melanoma. Despite the encouraging clinical potential of LAG-3, the physiological function and mechanism of action in tumors are still not well understood. In this review, we systematically summarized the structure of LAG-3, ligands of LAG-3, cell-specific functions and signaling of LAG-3, and the current status of LAG-3 inhibitors under development.

Schlagwörter

Stichwörter der Autor:innen

LAG-3PD-1immunotherapyrelatlimabtumor

Autor:innen und Institutionen

  • Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Department of Abdominal Oncology, Division of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Zitieren

APA

Luo, Y., Cai, X., Yang, B., Lu, F., Yi, C., & Wu, G. (2024). Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1402837

Vancouver

Luo Y, Cai X, Yang B, Lu F, Yi C, Wu G. Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1402837

BibTeX
@article{Luo2024,
  author = {Luo, Yingzhe and Cai, Xuebin and Yang, Biao and Lu, Facheng and Yi, Cheng and Wu, Guoyu},
  title = {Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1402837}
}
Kostenlos starten →